Hypercholesterolemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female, aged 45-75 years of age; 2. Agree to sign an informed consent form; 3. Fasting serum LDL-C 3.4-6.0 mmol/L.
Exclusion criteria
Exclusion criteria: 1. Subjects who decide to withdraw after signing the informed consents forms; 2. Patients who are currently taking or took lipid-lowering drugs or lipid-lowering health care products within 3 months; 3. Patients with milk allergy or lactose intolerance; 4. Patients enrolled in any other clinical trials now or within 4 weeks before being enrolled in this study; 5. Pregnant women or women giving breast-feeding; 6. Patients with concomitant severe cardiac disorder, electrolyte imbalance, liver and kidney dysfunction, or with other conditions not suitable for participating in the study at the investigator's discreet; 7. Patients with poor compliance; 8. Patients with other conditions not suitable for participating in the study at the investigator's discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL-C; | — |
Countries
China
Contacts
Huadong Hospital Affiliated to Fudan University